Accelerating COVID Trial Setup with Integrated eSource Technology

When speed and safety are paramount, how do you rapidly deploy a clinical trial during a global pandemic while minimizing infection risk?

 

This case study demonstrates how an emerging biopharma company eliminated paper-based processes and COVID cross-contamination concerns through integrated eSource EDC technology. Discover how unified electronic data capture, remote eConsent, and streamlined site workflows enabled a Phase 2 infectious disease trial to launch two weeks ahead of schedule—while reducing site burden during critical staff shortages.

 

Learn practical strategies for implementing paperless data collection, enabling remote consent for legally authorized representatives, and deploying multiple eClinical solutions through a single, intuitive platform.